Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Acotec Scientific Holdings Limited ( (HK:6669) ) has provided an update.
Acotec Scientific Holdings Limited has received approval from the PRC National Medical Products Administration for its Peripheral High-pressure Balloon Dilation Catheter, Armoni-HP®. This product is designed for use in percutaneous transluminal angioplasty in peripheral blood vessels and post-stent dilation, offering a high-strength fiber-composite design to ensure optimal clinical performance. The approval marks a significant step in the company’s product development, potentially enhancing its market position in the PRC healthcare sector.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, focusing on medical products. The company’s primary products include advanced medical devices such as balloon dilation catheters, targeting the healthcare industry with a focus on innovative solutions for vascular treatments.
Average Trading Volume: 287,378
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.38B
Learn more about 6669 stock on TipRanks’ Stock Analysis page.